FALVAX

This brand name is authorized in Romania

Active ingredients

The drug FALVAX contains one active pharmaceutical ingredient (API):

1 Fulvestrant
UNII 22X328QOC4 - FULVESTRANT

Fulvestrant is a competitive estrogen receptor (ER) antagonist with an affinity comparable to estradiol. Fulvestrant blocks the trophic actions of estrogens without any partial agonist (estrogen-like) activity.

Read about Fulvestrant

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L02BA03 Fulvestrant L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02B Hormone antagonists and related agents → L02BA Anti-estrogens
Discover more medicines within L02BA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W64160001, W64160002, W64160003, W64160004

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.